Three out of four selected markers (SEPT9, KCNQ5, and C9orf50) were successfullyadapted, with significantly higher methylation ratios (p ≤ 0.001) in the EO-CRC cohort. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.